BCYC (NASDAQ:BCYC) Target Raised by JMP Securities to $85.00

StockMarketDaily.co reports: Bicycle Therapeutics stock has undergone multiple analysts rating changes in the recent past.  Bicycle Therapeutics stock Target Raised by   JMP Securities on 10/14/2021. In a note to investors, the firm issued a new target price of $85.00. The analysts previously had $53.00 target price.

View More BCYC (NASDAQ:BCYC) Target Raised by JMP Securities to $85.00

Bicycle Therapeutics (NASDAQ:BCYC) Downgraded by Zacks Investment Research to Sell

Bicycle Therapeutics} stock has undergone multiple analysts rating changes in the recent past.  Bicycle Therapeutics Downgraded by Zacks Investment Research on 10-12-21. In a note to investors, the firm issued a new rating of Sell. The analysts previously had rating of Buy.

View More Bicycle Therapeutics (NASDAQ:BCYC) Downgraded by Zacks Investment Research to Sell

Bicycle Therapeutics (BCYC) Upgraded by Zacks Investment Research to Buy

Bicycle Therapeutics} stock has undergone multiple analysts rating changes in the recent past.  Bicycle Therapeutics Upgraded by Zacks Investment Research on 10-11-21. In a note to investors, the firm issued a new rating of Buy. The analysts previously had rating of Hold.

View More Bicycle Therapeutics (BCYC) Upgraded by Zacks Investment Research to Buy